| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/21/2008 | US20080044878 Novel Promoters |
| 02/21/2008 | US20080044874 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044873 Nucleic acid with beta-keto acyl-ACP synthase (KS) activity, chain length factor (CLF) activity, acyl transferase (AT) activity, and enoyl ACP-reductase (ER) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
| 02/21/2008 | US20080044872 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044871 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044870 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044869 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
| 02/21/2008 | US20080044868 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044867 Pufa polyketide synthase systems and uses thereof |
| 02/21/2008 | US20080044863 biosynthesis of inosine and guanosine in E coli modified to inactivate a purine repressor |
| 02/21/2008 | US20080044862 Nucleic Acid Linkers and Use Thereof in Gene Synthesis |
| 02/21/2008 | US20080044860 Polyketides and Their Synthesis |
| 02/21/2008 | US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof |
| 02/21/2008 | US20080044858 Using trangenic fungus to produce heterologous proteins; culturing |
| 02/21/2008 | US20080044856 Thermostable proteins and methods of making and using thereof |
| 02/21/2008 | US20080044855 System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells |
| 02/21/2008 | US20080044854 Site-specific incorporation of amino acids into molecules |
| 02/21/2008 | US20080044853 Stably Maintained Multiple Copies of at Least Two Orf in the Same Orientation |
| 02/21/2008 | US20080044845 Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans |
| 02/21/2008 | US20080044839 Methods and compositions for diagnosing lung cancer |
| 02/21/2008 | US20080044836 Nucleic Acid Analysis Using Non-templated Nucleotide Addition |
| 02/21/2008 | US20080044835 Mammalian chemokine reagents |
| 02/21/2008 | US20080044825 Method for Modulating the Evolution of a Polypeptide Encoded by a Nucleic Acid Sequence |
| 02/21/2008 | US20080044820 La1 - the genome of a lactobacillus strain |
| 02/21/2008 | US20080044819 Genetic Reference Materials |
| 02/21/2008 | US20080044815 Genetic Screen for Interaction Interface Mapping |
| 02/21/2008 | US20080044812 Melting Temperature Dependent Dna Amplification |
| 02/21/2008 | US20080044808 West nile virus antigen and assay |
| 02/21/2008 | US20080044806 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads |
| 02/21/2008 | US20080044549 Methods and compositions for modifying levels of secondary metabolic compounds in plants |
| 02/21/2008 | US20080044520 Phytase active yeast |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044438 Yeast Cell Particles As Oral Delivery Vehicles For Antigens |
| 02/21/2008 | US20080044437 Encapsidation System for Production of Recombinant Virus-Like Particles |
| 02/21/2008 | US20080044435 Tat-Based Tolerogen Compositions and Methods of Making and Using Same |
| 02/21/2008 | US20080044432 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080044429 Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof |
| 02/21/2008 | US20080044427 Plant virus |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044424 Antagonists of protease activated receptor-1 (par1) |
| 02/21/2008 | US20080044423 Compounds |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044421 Methods of using death receptor ligands and CD20 antibodies |
| 02/21/2008 | US20080044420 Anti-IL-13 antibodies, compositions, methods and uses |
| 02/21/2008 | US20080044418 Tumor Antigens and Uses Thereof |
| 02/21/2008 | US20080044417 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA |
| 02/21/2008 | US20080044415 Hepatocyte growth factor receptor antagonists and uses thereof |
| 02/21/2008 | US20080044414 IL-1beta binding antibodies and fragments thereof |
| 02/21/2008 | US20080044412 Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044410 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement; disorders of insulin metabolism |
| 02/21/2008 | US20080044407 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 02/21/2008 | US20080044403 Immune Markers Used for Diagnosis and Therapy in Connection With Transplant Reactions |
| 02/21/2008 | US20080044394 Methods for genetic modification of hematopietic progenitor cells and uses of the modified cells |
| 02/21/2008 | US20080044393 Retinal dystrophin transgene and methods of use thereof |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044386 Protamine-Adenoviral Vector Complexes and Methods of Use |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044378 Methods and Compositions for Protein Production Using Adenoviral Vectors |
| 02/21/2008 | US20080044377 Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine |
| 02/21/2008 | US20080043117 Method and Apparatus for Compensating Image Sensor Lens Shading |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | DE102006037580A1 Sandel-Duftstoffrezeptoren Sandalwood scent receptors |
| 02/21/2008 | CA2853387A1 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 02/21/2008 | CA2696953A1 Nested binary code symbol |
| 02/21/2008 | CA2678051A1 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/21/2008 | CA2662826A1 Method and apparatus for microfluidic injection |
| 02/21/2008 | CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 02/21/2008 | CA2661023A1 Prlr-specific antibody and uses thereof |
| 02/21/2008 | CA2660516A1 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | CA2660513A1 System, method, and device for the expression or repression of proteins |
| 02/21/2008 | CA2660490A1 Leptin and growth hormone receptor gene markers associated with rearing, carcass traits and productive life in cattle |
| 02/21/2008 | CA2660487A1 Association of single nucleotide polymorphisms, dairy form and productive life |
| 02/21/2008 | CA2660485A1 Zinc finger nuclease-mediated homologous recombination |
| 02/21/2008 | CA2660321A1 Differential labeling of cells |
| 02/21/2008 | CA2660204A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | CA2660171A1 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 02/21/2008 | CA2660147A1 Re-engineering bacteria for ethanol production |
| 02/21/2008 | CA2659267A1 Influenza hemagglutinin and neuraminidase variants |
| 02/21/2008 | CA2659252A1 Plants with enhanced size and growth rate |
| 02/21/2008 | CA2658557A1 Optimized antibodies that target cd19 |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/21/2008 | CA2656598A1 Hybrid promoters |
| 02/21/2008 | CA2656430A1 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 02/21/2008 | CA2654968A1 Identification of genes implicated in the virulence of streptococcus agalactiae |
| 02/20/2008 | EP1890146A1 Method for detecting of nucleic acid |
| 02/20/2008 | EP1889921A2 Solution for the indefinite maintenance of nucleic acids in the cell of origin thereof |
| 02/20/2008 | EP1889917A2 Methods and cells for expression of recombinant protein products |
| 02/20/2008 | EP1889916A1 A method for the production of the recombinant hoxb4 protein containing his tag at c-terminal and use thereof |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889913A1 Transcription factor islet-brain 1 (IB1) |
| 02/20/2008 | EP1889912A1 Transcriptions Factor Islet-Brain 1 (IB1) |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889910A2 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| 02/20/2008 | EP1889909A1 Improvement of disease resistance of plant by introducing transcription factor gene |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |